AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 85, Issue 10 1356-1360, Copyright © 1995 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJPH
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrow, R H
Right arrow Articles by Bryant, J H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrow, R H
Right arrow Articles by Bryant, J H
Health policy approaches to measuring and valuing human life: conceptual and ethical issues.

R H Morrow and J H Bryant

Department of International Health, School of Hygiene and Public Health, USA.

To achieve more cost-effective and equitable use of health resources, improved methods for defining disease burdens and for guiding resource allocations are needed by health care decision makers. Three approaches are discussed that use indicators that combine losses due to disability with losses due to premature mortality as a measure of disease burden. These indicators can also serve as outcome measures for health status in economic analyses. However, their use as tools for measuring and valuing human life raises important questions concerning the measurement of mortality and the multidimensions of morbidity; valuing of life, particularly regarding weighting productivity, dependency, age, and time-preference factors; and conflicts between equity and efficiency that arise in allocation decisions. Further refinement of these tools is needed to (1) incorporate national and local values into weighting; (2) elaborate methods for disaggregating calculations to assess local disease patterns and intervention packages; and (3) develop guidelines for estimating marginal effects and costs of interventions. Of utmost importance are methods that ensure equity while achieving reasonable efficiency.


Related articles in AJPH:

Beyond population statistics.
G Silver
AJPH 1995 85: 1345-1346. [PDF]  



This article has been cited by other articles:


Home page
Diabetes CareHome page
American Diabetes Association
Economic Costs of Diabetes in the U.S. in 2007
Diabetes Care, March 1, 2008; 31(3): 596 - 615.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. P. Gross, G. F. Anderson, and N. R. Powe
The Relation between Funding by the National Institutes of Health and the Burden of Disease
N. Engl. J. Med., June 17, 1999; 340(24): 1881 - 1887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Public Health Association